The pathogens considered most dangerous to human health included Aspergillus fumigatus, which comes from mold and infects the ...

F2G submitted its initial approval application with data from the first 100 patients enrolled in a phase 2b study of the drug ...

F2G said on Thursday it has raised $100 million from investors including AMR Action Fund, backed by large drugmakers such as Johnson & Johnson and Pfizer, to help it develop treatments for infections ...

Without immediate action, humanity will potentially face further escalation in resistance in fungal disease, a group of scientists from the around the world has warned. According to the scientists ...

Kerassentials is a novel formula designed to combat antifungal resistance and alleviate toenail itching. The formula h ...

UK-based biopharmaceutical company F2G announced a $100 million financing round to advance late-stage development and ...

Olorofim is licensed in Europe and Asia to Japanese pharma Shionogi, which paid $100 million upfront for rights to the drug ...

Read this Kerassentials review to find out if this formula effectively supports nail health by addressing fungal infections.

U.K.-based biotechnology company F2G has raised $100 million to complete late-stage testing of a new kind of antifungal ...

Without immediate action, humanity will potentially face further escalation in resistance in fungal disease, a renowned group of scientists from the across the world has warned.

Discover the truth with our KeraBiotics reviews, exploring how this advanced probiotic mix can effectively combat toenail ...

Basilea Pharmaceutica has entered into a multi-year agreement with the Biomedical Advanced Research and Development Authority ...